Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2015) 37 EP783 | DOI: 10.1530/endoabs.37.EP783

Hospital Universitario Central de Asturias, Oviedo, Spain.


Object: Nonfunctioning pituitary adenomas can experiment recurrence and/or progression (R/P) several years after surgery in about 15–50% of patients. There is few evidence about risk factors that could predict R/P. The aim of this study is to identify them and describe our experience through a long term of follow-up in pituitary macroadenomas.

Methods: Retrospective cohort analysis of 64 patients who underwent surgery between 1990 and 2013. The main outcome was to evaluate prevalence of R/P during the follow-up, based on imaging criteria and identify some risk factors for R/P.

Results: Over a median follow-up of 10.12 years, there was 46% of R/P after surgery at a median time of 4.6 years, the cumulative risk of being free of R/P was 62% by 5 years and decrease to 45% by 15 years after surgery. Multivariate cox proportional hazard regression analysis identified the following risk factors as associated with increased risk of recurrence: radiotherapy after surgery (hazard ratio 2.90, 95% CI 1.15–7.46, P=0.023) and the tumour size at diagnosis (hazard ratio 1.05 CI 1.009–1.10, P=0.019).

Conclusions: Patients with NFPA need long-term follow-up because they have a high risk of R/P over time. Radiotherapy after surgery decreases the risk of recurrence or progression specially after five years. The tumour size at diagnosis is an independently risk of R/P.

Article tools

My recent searches

No recent searches.